drugset / Trial / NCT00697086
European Study of Dronedarone in Atrial Fibrillation
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to assess the efficacy of dronedarone for the control of ventricular rate at rest and during exercise in patients with atrial fibrillation (AF) and to assess the tolerability of dronedarone in the target population.
Timeline
- Start
- 2002-08
- Primary completion
- 2004-06
- Completion
- 2004-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dronedarone | Small molecule | 400 mg | — |